Results of a mid-term trial for the novel coronavirus vaccine Developed by AstraZeneca. And the University of Oxford Showed a favorable immune response in the elderly population. Which is the group most at risk of getting this disease
Dr. Maheshi Ramasami, an Oxford advisor and research team leader, said: “Populations at the greatest risk of getting COVID-19 are likely to develop. With severe symptoms, including those slotxo เล่นฟรี with existing health problems and the elderly We hope that our vaccines will help protect society's most vulnerable people. But more research is needed to be sure. "
The said disclosure This is in line with research published today in the medical journal The Lancet, which suggests that people over 70% are at a higher risk of developing severe symptoms and dying from COVID-19.